Infective endocarditis (IE) remains a rare condition but one with high associated morbidity
and mortality. With an ageing population and increasing use of implantable cardiac devices
and heart valves, the epidemiology of IE has changed. Early clinical suspicion and a rapid
diagnosis are essential to enable the correct treatment pathways to be accessed and to
reduce complication and mortality rates. In the current review, we detail the latest guidelines
for the evaluation and management of patients with endocarditis and its prevention.